logoTry Persana

BenevolentAI - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about BenevolentAI including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

BenevolentAI company logo

Leveraging AI to accelerate biopharma drug discovery.

BenevolentAI is a leader in applying AI to accelerate biopharma drug discovery and development, combining advanced technology with scientific expertise.

HeadquartersLondon, United Kingdom
Team size251-500
Founded2013

What is BenevolentAI? - Company Overview & Details

BenevolentAI is BenevolentAI is a leader in applying AI to accelerate biopharma drug discovery and development, combining advanced technology with scientific expertise. Founded in 2013, the company is headquartered in London, United Kingdom.

Who Founded BenevolentAI?

BenevolentAI was founded by Kenneth Mulvany.

Who are the Key Executives at BenevolentAI? - Leadership Team

BenevolentAI is led by experienced executives in key positions:

Chief Executive Officer (CEO) of BenevolentAI

Dr. Joerg MoellerCEO

Chief Technology Officer (CTO) of BenevolentAI

Michael BrennanCTO

About Dr. Joerg Moeller - CEO of BenevolentAI

Dr. Joerg Moeller serves as the Chief Executive Officer of BenevolentAI, leading the company's strategic vision and operations.

BenevolentAI Company Details & Key Information

Where is BenevolentAI located?

BenevolentAI is headquartered in London, United Kingdom.

How many employees does BenevolentAI have?

BenevolentAI has 251-500 employees.

When was BenevolentAI founded?

BenevolentAI was founded in 2013.

BenevolentAI Official Website

How much funding has BenevolentAI raised?

BenevolentAI has raised undisclosed amount.

N/A
Total Funding Raised
0
Funding Rounds
N/A
Latest Round

Who are the key investors in BenevolentAI?

Investor Information Not Available

Detailed information about BenevolentAI investors is not currently available in our database.

What are BenevolentAI's future plans?

BenevolentAI BenevolentAI aims to capitalize on its unique position in AI-driven drug discovery and enhance partnerships with pharmaceutical companies.

BenevolentAI Strategic Outlook

Strategic Focus
Defined
0
Key Challenges
0
Growth Opportunities

What are the latest news about BenevolentAI?

BenevolentAI has 2 recent news updates covering key business developments and market activities.

BenevolentAI News Overview

2
Recent Articles
Active
Media Coverage
2024-10-17
Latest Update

What is BenevolentAI in the news for?

BenevolentAI is currently featured in news for Benevolent hires Michael Brennan as Chief Strategy and Financial Officer. and other significant business developments.

Recent News Articles About BenevolentAI

Article 1
2024-10-17

Benevolent hires Michael Brennan as Chief Strategy and Financial Officer.

BenevolentAI appoints Michael Brennan as Chief Strategy and Financial Officer, enhancing leadership.

businesswire.com
Read News
Article 2
2024-10-17

Benevolent hires Kenneth Mulvany as Executive Chairman.

Kenneth Mulvany appointed as Executive Chairman of BenevolentAI, aiming to drive healthcare innovation.

businesswire.com
Read News

BenevolentAI FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about BenevolentAI including information about founders, CEO, funding history, investors, headquarters location, and company details. 11 frequently asked questions covering key information about the company.

BenevolentAI Questions & Answers - Company Information

Q1

What is BenevolentAI?

BenevolentAI is a leader in applying AI to accelerate biopharma drug discovery and development, combining advanced technology with scientific expertise.

Q2

Who founded BenevolentAI?

BenevolentAI was founded by Kenneth Mulvany.

Q3

Who is the CEO of BenevolentAI?

The CEO of BenevolentAI is Dr. Joerg Moeller.

Q4

Where is BenevolentAI headquartered?

BenevolentAI is headquartered in London, United Kingdom.

Q5

When was BenevolentAI founded?

BenevolentAI was founded in 2013.

Q6

How many employees does BenevolentAI have?

BenevolentAI has 251-500 employees.

Q7

What is BenevolentAI's official website?

You can visit BenevolentAI's official website at https://benevolent.ai/.

Q8

Who is founder?

Kenneth Mulvany

Q9

Who is cto?

Michael Brennan

Q10

What does the company do?

BenevolentAI leverages AI to accelerate biopharma drug discovery and development.

Q11

Latest news?

BenevolentAI appoints Michael Brennan as Chief Strategy and Financial Officer, enhancing leadership. Kenneth Mulvany appointed as Executive Chairman of BenevolentAI, aiming to drive healthcare innovation.

More Information About BenevolentAI

For additional details about BenevolentAI, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.